Neuraxis, Inc. amended its existing At The Market (ATM) Offering Agreement with Craig-Hallum Capital Group LLC. The company increased the total aggregate offering price of common stock available for sale from $6,270,000 to $11,500,000. Between August 29, 2025, and April 20, 2026, the company sold 1,125,281 shares under the original agreement. The offering is conducted under an effective Registration Statement on Form S-3.